Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrienne Shnier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The International Journal of Risk & Safety in Medicine|September 9, 2017
Continuing medical education and pharmaceutical industry involvement: An evaluation of policies adopted by Canadian professional medical associationsAdrienne Shnier, Joel Lexchin
BMJ (Clinical Research Ed.)|July 21, 2017
Regulatory data are hidden in plain sightHarriet G Rosenberg, Adrienne Shnier
BMJ Open|March 10, 2022
National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional studyJoel Lexchin, Sharon Batt, Devorah Goldberg, et al.
BMC Health Services Research|August 17, 2016
Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association InfobaseAdrienne Shnier, Joel Lexchin, Mirna Romero, et al.
Plos One|July 18, 2013
Too few, too weak: conflict of interest policies at Canadian medical schoolsAdrienne Shnier, Joel Lexchin, Barbara Mintzes, et al.
Health Policy (Amsterdam, Netherlands)|April 2, 2018
Decoding disclosure: Comparing conflict of interest policy among the United States, France, and AustraliaQuinn Grundy, Roojin Habibi, Adrienne Shnier, et al.
Health Policy (Amsterdam, Netherlands)|January 14, 2020
Variation in the prescription drugs covered by health systems across high-income countries: A review of and recommendations for the academic literatureSteven G Morgan, Jamie R Daw, Devon Greyson, et al.
Indian Journal of Medical Ethics|March 19, 2018
Combating corruption in the pharmaceutical arenaJoel Lexchin, Jillian Clare Kohler, Marc André Gagnon, et al.
The Journal of the Canadian Chiropractic Association|December 22, 2025
Conceptualizing clinical expertise in evidence-based practice: a narrative literature review with implications for clinical decision-makingDeborah Kopansky-Giles, Jonathan Murray, Jessica M Parish, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 16, 2020
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive studyKatharine Elder, Kimberly A Turner, Lisa Cosgrove, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The International Journal of Risk & Safety in Medicine|September 9, 2017
Continuing medical education and pharmaceutical industry involvement: An evaluation of policies adopted by Canadian professional medical associationsAdrienne Shnier, Joel Lexchin
BMJ (Clinical Research Ed.)|July 21, 2017
Regulatory data are hidden in plain sightHarriet G Rosenberg, Adrienne Shnier
BMJ Open|March 10, 2022
National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional studyJoel Lexchin, Sharon Batt, Devorah Goldberg, et al.
BMC Health Services Research|August 17, 2016
Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association InfobaseAdrienne Shnier, Joel Lexchin, Mirna Romero, et al.
Plos One|July 18, 2013
Too few, too weak: conflict of interest policies at Canadian medical schoolsAdrienne Shnier, Joel Lexchin, Barbara Mintzes, et al.
Health Policy (Amsterdam, Netherlands)|April 2, 2018
Decoding disclosure: Comparing conflict of interest policy among the United States, France, and AustraliaQuinn Grundy, Roojin Habibi, Adrienne Shnier, et al.
Health Policy (Amsterdam, Netherlands)|January 14, 2020
Variation in the prescription drugs covered by health systems across high-income countries: A review of and recommendations for the academic literatureSteven G Morgan, Jamie R Daw, Devon Greyson, et al.
Indian Journal of Medical Ethics|March 19, 2018
Combating corruption in the pharmaceutical arenaJoel Lexchin, Jillian Clare Kohler, Marc André Gagnon, et al.
The Journal of the Canadian Chiropractic Association|December 22, 2025
Conceptualizing clinical expertise in evidence-based practice: a narrative literature review with implications for clinical decision-makingDeborah Kopansky-Giles, Jonathan Murray, Jessica M Parish, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 16, 2020
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive studyKatharine Elder, Kimberly A Turner, Lisa Cosgrove, et al.
Pageof 2